Zyme Tech

 

BLG GROUP has been committed to the research and development and application of enzyme-based technologies, aiming to solve problems in the fields of industry, medicine, environmental protection, etc. through biocatalysis technology. As an important biological catalyst in nature, enzymes are highly efficient, specific, and environmentally friendly, with broad prospects for application in the pharmaceutical, chemical, food, skin care and other industries.

 

Dr. Zhou Xunyong, the founder of BLG, has proposed a series of innovative theories, including enzyme-based food theory, 5A theory, enzyme and immune balance theory (DZ-EBIRB), and three-factor network theory with enzyme factors as the core.

Based on its unique theories, BLG has developed a series of world-leading technologies, including: enzyme activation technology, EACT process, phospholipase synthesis and application technology, synthetic enzyme development technology, enzyme-based new raw material technology, enzyme-based probiotic technology, IRB-Enzyme integrated technology, innovative cell therapy MTS and ILDT new technologies.

BLG's original multi-enzyme tablet compound preparation process completely subverts the traditional tablet production process, allowing the protease activity to be stably preserved in the tablet, and quickly released after entering the intestine, to maximize the effect on the human body.

BLG GROUP's research directions are "Enzymes and Enzyme Preparations", "Enzyme-based Food Theory", "Enzyme Activation Technology" and "Enzyme-based Immunity in Balance Theory". It has published many enzyme-based theory monographs and many internationally recognized researched papers. In addition, they have dozens of enzyme technology invention patents and honors, including 2 technical secrets (KNOW-HOW), more than 30 patents, more than 150 trademarks, and 2 copyrights.